Milk exosomes are bioavailable
and distinct microRNA cargos have
unique tissue distribution patterns by Manca, Sonia et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Nutrition and Health Sciences -- Faculty
Publications Nutrition and Health Sciences, Department of
2018
Milk exosomes are bioavailable and distinct
microRNA cargos have unique tissue distribution
patterns
Sonia Manca
University of Nebraska - Lincoln, sonia.manca@unmc.edu
Bijaya Upadhyaya
University of Nebraska - Lincoln, bupadhyaya2@unl.edu
Ezra Mutai
University of Nebraska - Lincoln, emutai2@unl.edu
Amy T. Desaulniers
University of Nebraska - Lincoln
Rebecca A. Cederberg
University of Nebraska - Lincoln
See next page for additional authors
Follow this and additional works at: http://digitalcommons.unl.edu/nutritionfacpub
Part of the Human and Clinical Nutrition Commons, Molecular, Genetic, and Biochemical
Nutrition Commons, and the Other Nutrition Commons
This Article is brought to you for free and open access by the Nutrition and Health Sciences, Department of at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Nutrition and Health Sciences -- Faculty Publications by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.
Manca, Sonia; Upadhyaya, Bijaya; Mutai, Ezra; Desaulniers, Amy T.; Cederberg, Rebecca A.; White, Brett R.; and Zempleni, Janos,
"Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns" (2018). Nutrition and Health
Sciences -- Faculty Publications. 147.
http://digitalcommons.unl.edu/nutritionfacpub/147
Authors
Sonia Manca, Bijaya Upadhyaya, Ezra Mutai, Amy T. Desaulniers, Rebecca A. Cederberg, Brett R. White, and
Janos Zempleni
This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/nutritionfacpub/147
1Scientific REPORTS |  (2018) 8:11321  | DOI:10.1038/s41598-018-29780-1
www.nature.com/scientificreports
Milk exosomes are bioavailable 
and distinct microRNA cargos have 
unique tissue distribution patterns
Sonia Manca  1, Bijaya Upadhyaya  1, Ezra Mutai1, Amy T. Desaulniers2, 
Rebecca A. Cederberg2, Brett R. White2 & Janos Zempleni  1
Exosomes participate in cell-to-cell communication, facilitated by the transfer of RNAs, proteins and 
lipids from donor to recipient cells. Exosomes and their RNA cargos do not exclusively originate from 
endogenous synthesis but may also be obtained from dietary sources such as the inter-species transfer 
of exosomes and RNAs in bovine milk to humans. Here, we assessed the bioavailability and distribution 
of exosomes and their microRNA cargos from bovine, porcine and murine milk within and across species 
boundaries. Milk exosomes labeled with fluorophores or fluorescent fusion proteins accumulated in 
liver, spleen and brain following suckling, oral gavage and intravenous administration in mice and pigs. 
When synthetic, fluorophore-labeled microRNAs were transfected into bovine milk exosomes and 
administered to mice, distinct species of microRNAs demonstrated unique distribution profiles and 
accumulated in intestinal mucosa, spleen, liver, heart or brain. Administration of bovine milk exosomes 
failed to rescue Drosha homozygous knockout mice, presumably due to low bioavailability or lack of 
essential microRNAs.
Virtually every living cell synthesizes and secretes exosomes into the extracellular space1,2. Exosomes play an 
essential role in cell-to-cell communication, which is achieved through the transfer of exosome cargos, such as 
various species of RNAs, lipids and proteins, from donor cells to adjacent or distant recipient cells1,3. In recipi-
ent cells, exosome cargos regulate gene expression and metabolism. The roles of microRNAs in communication 
through exosomes has been particularly well characterized because microRNAs regulate the expression of more 
than 60% of mRNAs in humans and loss of microRNA maturation in Drosha knockout mice results in prema-
ture lethality4. MicroRNAs have been implicated in many, if not all, physiological and pathological conditions 
in humans5–7. For example, adipocyte-derived exosomes participate in transforming growth factor-β dysregu-
lation in hepatocytes and obesity-related liver disease; these effects are facilitated by exosome-dependent shut-
tling of microRNAs from donor to recipient cells8,9. Notwithstanding the great importance of microRNA cargos 
in exosome-mediated communication, protein cargos may also play important roles in human physiology and 
pathology. For example, exosomes appear to participate in the spread of β-amyloid and α-synuclein in the prop-
agation and diagnosis of Alzheimer’s Disease and Parkinson’s Disease10–12.
Previously, we provided evidence that exosomes and their cargos not only originate from endogenous synthe-
sis but may also be obtained from dietary sources, including the transfer of bovine milk exosomes across species 
boundaries13–17. Specifically, we demonstrated that human intestinal and vascular endothelial cells, as well as rat 
intestinal cells, transport bovine milk exosomes into the cytoplasm by endocytosis and release their microRNA 
cargos across the basolateral membrane in cell cultures. Independent laboratories have corroborated these find-
ings, including studies in mouse models18–21. Moreover, pigs-derived exosomes were demonstrated to be able to 
increase intestinal cell proliferation and development of intestinal tract in mice22.
The cargo of dietary exosomes appears to be biologically active. For example, microRNAs in bovine milk 
exosomes decreased the expression of genes in circulating immune cells in human feeding studies and in human 
kidney cell cultures13 and miR-148a in human milk downregulated the expression of DNA methyltransferase 1 
in normal human colon cells and human leukemia cells21. Dietary microRNAs, encapsulated in milk exosomes, 
are protected against degradation by low pH, RNases and treatment that mimics digestion in the gastrointestinal 
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tract23–25. Dietary depletion of exosomes and their cargos result in a phenotype of aberrant metabolism of purines 
as well as impaired spatial learning and memory in preliminary studies of humans and mice26,27. These obser-
vations raise concerns regarding infant nutrition by using formulas, because the content of microRNAs is lower 
compared to human milk23. The regulation of genes and metabolism by bovine milk exosomes and their cargos 
across species boundaries suggests that these compounds might represent novel classes of bioactive food com-
pounds, as defined by the National Cancer Institute as “a type of chemical found in small amounts in plants 
and certain foods […]. Bioactive compounds have actions in the body that may promote good health and they 
are being studied in the prevention of […] diseases”28. That said, milk might have effects detrimental to health, 
although adverse effects of milk have not been formally linked with exosomes29,30. Finally, bovine milk exosomes 
are considered scalable vehicles for the delivery of unstable or poorly bioavailable drugs19,20.
Despite the great interest in bovine milk exosomes and their enormous potential in nutrition and pharma-
cology, we know little about the bioavailability and distribution of bovine milk exosomes in non-bovine species. 
Notable exceptions include evidence that (i) macrophages rapidly eliminate foreign exosomes in mice, (ii) bovine 
exosomes can be found in murine tissues following oral administration, and (iii) human intestinal cells transport 
distinct species of microRNAs, encapsulated in bovine milk exosomes, with varying efficacy15,19,31. Here, we pro-
vide evidence that the bioavailability and distribution of microRNAs, encapsulated in bovine milk exosomes, var-
ies among different species of microRNA. Our study also suggests that milk exosomes deliver protein and RNA 
cargos to the brain, which is consistent with previous reports that genetically engineered murine exosomes deliver 
Cre recombinase to the brain following nasal administration in mice, and feeding an exosome- and RNA-depleted 
diet impairs spatial learning and memory in mice27,32.
Results
Bioavailability and distribution of milk exosomes and protein cargos. DiR-labeled bovine milk 
exosomes administered to adult Balb/c mice through oral gavage yielded a greater fluorescent signal than con-
trol animals receiving either free DiR or unlabeled exosomes (see below). The signal produced by free DiR was 
stronger than the signal produced by unlabeled exosomes; thus, the signals produced by free DiR and DiR-labeled 
exosomes were compared in all statistical analyses of densitometry data, but the signal produced by unlabeled 
exosomes served as controls in the bar graphs (see Discussion). The signal produced by DiR-labeled bovine milk 
exosomes was greater than that produced by free DiR in liver, spleen and, to a lesser extent, in lungs 3 hours after 
intravenous injection, but was significantly higher only in liver 24 hours after oral gavage in female Balb/c mice 
(Fig. 1a–e and Supplementary Fig. 1). The tissue accumulation of DiR-labeled milk exosomes was not higher 
than that of free DiR in male mice (Supplementary Fig. 2). Time course analyses suggested that exosome concen-
trations in liver and spleen peaked 3 hours after intravenous injection and decreased slightly at subsequent time 
points (Fig. 1a,b). In contrast, the exosome signal in the liver peaked 24 hours after oral gavage, and no signal was 
detectable 48 hours after administration (Fig. 1d). A dose-dependent increase in the DiR-exosome signal was 
observed, suggesting that the minimal doses detectable after intravenous and oral administration were 1 × 1010 
exosomes/g and 1 × 1012 exosomes/g body weight, respectively (Fig. 1f–i and Supplementary Fig. 3). For compar-
ison, our purification protocol yielded about 7 × 1010 exosomes/ml of commercial bovine milk.
We attempted to assess the approximate bioavailability of orally versus intravenously administered bovine 
milk exosomes by comparing the DiR signal pooled from all murine organs following oral gavage and intravenous 
injection. When DiR signals were compared 24 hours after oral gavage to 3 hours or 24 hours after intravenous 
injection, the apparent bioavailability was 3.9 ± 2.1% and 5.9 ± 2.6%, respectively. These estimates are substan-
tially lower than those based upon using fluorophore-labeled miR-320a as a marker (see below).
Bioavailability and tissue distribution were altered when exosomes were ultrasonicated or treated with trypsin 
prior to labeling with DiR (Supplementary Fig. 4). In previous studies, we showed that ultrasonication causes 
a change in exosomes morphology and substantial loss in RNA cargos, whereas removal of surface proteins 
by protease treatment causes a loss in exosome uptake by intestinal and vascular endothelial cells13,15,16,33. In 
this study, ultrasonication of exosome caused a loss of bioavailability to levels near the detection limit after oral 
administration (Supplementary Fig. 4a). Removal of exosomal surface proteins by treatment with trypsin caused 
a reduced accumulation of exosomes in the liver and homing to lungs and spleen after intravenous injection 
(Supplementary Fig. 4b). Depletion of macrophages by treating mice with clodronate resulted in an almost exclu-
sive accumulation of exosomes in the liver after oral gavage (Supplementary Fig. 5).
When working with lipophilic fluorophores such as DiR, the transfer of dyes from the labeled complex to 
other complexes is a concern34. Here, we used milk from transgenic pigs and mice to assess the bioavailability and 
distribution of endogenously-labeled exosomes delivered at physiologically relevant doses through the natural 
route of suckling. The transgenic pigs and C57BL/6 mice produced milk in which exosomes were endogenously 
labeled with ZsGreen1 or an enhanced green fluorescent protein (CD63/eGFP), respectively (not shown). While 
the signal of both green fluorescent proteins was not strong enough to assess bioavailability after a single oral 
dose (data not shown), both models allowed for the analysis of bioavailability and distribution of milk exosomes 
after intravenous injection and uptake through suckling. Exosomes endogenously labeled with ZsGreen1 in pig 
milk were detected in the liver and brain 3 hours after intravenous injection in female Balb/c mice (1 × 1012/g 
body weight) compared with the autofluorescence of organs from mice injected with wild-type (WT) porcine 
milk exosomes (Fig. 2a,b). Next, WT piglets were nursed by sows secreting ZsGreen1-positive milk exosomes 
for 17 days. When tissue extracts were probed with anti-ZsGreen1, we detected an immunoreactive protein with 
a molecular weight of approximately 26 kDa in cerebellum in eight of the 12 piglets that were tested (Fig. 2c); 
faint signals were also detected in the spleen in some pigs (Supplementary Fig. 6b lanes 5 and 8). The mass of 
the protein matched the expected molecular weight for ZsGreen35, suggesting absence of ZsGreen1 degradation. 
No band corresponding to the 26-kDa ZsGreen1 signal was detectable in cerebellum samples from WT pigs 
nursed by a WT dam or in stillborn WT pigs (Fig. 2c and Supplementary Fig. 6). The presence of ZsGreen1 in 
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exosomes was confirmed by using an iBox imaging system (Fig. 2d). A similar pattern of exosomes distribution 
was observed when WT mouse pups were nursed by CD63/eGFP-positive dams for 17 days (Fig. 2e). The eGFP 
signal was higher in heart, lungs, kidneys, brain and, to a lesser extent in liver in WT mice pups nursed by CD63/
eGFP-positive dams compared to WT pups nursed by WT dams (Fig. 2e,f).
Bioavailability and distribution of microRNA cargos. Distinct species of microRNAs in bovine milk 
exosomes showed unique profiles of bioavailability and distribution, and the distribution was dissimilar com-
pared to that of exosomes in Balb/c mice. As a first line of evidence, the entire pool of single-stranded RNAs in 
bovine milk exosomes was labeled using Exo-Glow Red. The majority of labeled RNA localized to brain after 
intravenous injection with peak levels occurring 2 hours after injection compared to controls injected with 
Figure 1. Absorption of bovine milk exosomes in mice. (a) DiR-labeled exosomes (1 × 1012/g body weight) 
3, 6 and 24 hours after intravenous injection in whole Balb/c mice (upper panels) and excised tissues (lower 
panels). (b) Densitometry analysis of fluorescence in excised tissues 3, 6 and 24 hours after intravenous injection 
of DiR-labeled exosomes. (c) Fluorescence in Balb/c mice 3, 6, 18, 24 or 48 hours after oral gavage of DiR-
labeled (right mouse) or unlabeled exosomes (left mouse; 1 × 1012/g body weight). (d) Fluorescence in excised 
organs of Balb/c mice 3, 6, 18, 24 or 48 hours after oral gavage of free DiR, unlabeled or DiR-labeled exosomes 
(1 × 1012/g body weight). (e) Densitometry analysis of fluorescence in excised tissues after oral gavage of 
unlabeled or DiR-labeled exosomes at 24 hours, normalized for plate background for each mouse analyzed. (f) 
Dose-response analysis of fluorescence in excised murine tissues 24 h after intravenous injection with unlabeled 
or DiR-labeled exosomes (1 × 1010/g, 1 × 1011/g, 1 × 1012/g body weight). (g) Densitometry analysis of excised 
tissues after intravenous injection of unlabeled or DiR-labeled exosomes for each mouse analyzed (1 × 1010/g, 
1 × 1011/g, 1 × 1012/g body weight). (h) Dose-response analysis of fluorescence in excised murine tissues 24 h 
after oral gavage with unlabeled or DiR-labeled exosomes (1 × 1011/g, 1 × 1012/g body weight) 24 h after oral 
gavage. (i) Densitometry analysis of excised tissues after oral gavage of unlabeled or DiR-labeled exosomes in 
dose-response experiments. Panels in this figure were assembled from multiple independent images and gels; 
individual images in the grouped figure are separated by white space.
www.nature.com/scientificreports/
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unlabeled exosomes (Supplementary Fig. 7). In contrast, after oral gavage the majority of the labeled RNA local-
ized to brain, kidneys and liver with peak levels occurring 12 hours after administration (Fig. 3a). Two controls, 
free Exo-Glow and unlabeled exosomes, produced a signal weaker than that produced by exosomal RNAs labeled 
with Exo-Glow following oral gavage.
Next, we devised a novel protocol and transfected bovine milk exosomes with synthetic IRDye-labeled 
microRNAs; exosomes treated IRDye-labeled microRNAs in the absence of transfection reagent were adminis-
tered to controls. The four microRNAs that were tested displayed unique patterns of tissue distribution. MiR-320a 
accumulated primarily in liver with small amounts being detectable in kidneys, lungs and spleen 3 hours after 
intravenous injection (Supplementary Fig. 8); in contrast, miR-320a accumulated primarily in liver, spleen and 
kidneys 6 hours after oral gavage, and the signals were greater than those produced by transfection reagent-free 
controls (Fig. 3b,c). IRDye is a near-infrared dye, which explains the strong signals produced by IRDye-labeled 
microRNAs compared with some of other labels used in our studies. When the fluorescent signal was compared 
after intravenous and oral administration, the apparent bioavailability of miR-320a was 25.4 ± 8.7%, based on 
the comparison of hepatic densitometry data 3 hours after intravenous injection and 6 hours after oral gavage. 
MiR-34a and miR-155-5p accumulated primarily in the brain and spleen, respectively, following oral gavage 
(Fig. 3d–g).
Figure 2. Absorption and distribution of murine and porcine milk exosomes endogenously labeled with 
fluorescent proteins in mice and pigs. (a) Fluorescence signal of porcine ZsGreen1 milk exosomes (upper panel) 
and WT exosomes (lower panel; 1 × 1012/g body weight) in murine tissues excised 3 hours after intravenous 
injection. (b) Densitometry analysis of fluorescence in tissues excised from mice injected with porcine 
ZsGreen1 or WT milk exosomes. (c) Western blot analysis of ZsGreen1 in protein extracts from WT piglets 
nursed by a transgenic ZsGreen1 sow for 17 days. Lanes: 1, Marker; 2, cerebellum in WT pig; 3, cerebellum in a 
stillborn (not nursed) WT pig; 4, cerebellum in WT pig nursed by a transgenic sow; and 5, marker. (d) Porcine 
milk exosomes purified from WT (left) and transgenic ZsGreen1 pigs (right). (e) CD63/eGFP-labeled exosomes 
in WT mouse pups nursed by an ECT transgenic dam for 17 days. (f) Densitometry analysis of fluorescence 
in tissues excised from WT pups nursed by an ECT transgenic dam for 17 days compared with tissues excised 
from WT pups nursed by WT dam for 17 days. Panels in this figure were assembled from multiple independent 
images and gels; individual images in the grouped figure are separated by white space.
www.nature.com/scientificreports/
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We used miR-375 to demonstrate that fluorophore labels remained attached to synthetic microRNAs after 
administration to mice. For this purpose, we synthesized miR-375 covalently labeled with both a fluorophore 
(5ATTO633N) and the corresponding quencher (3IAbRQSp). The intact microRNA did not emit fluorescence, 
but produced a signal when the quencher was removed from the fluorophore by treatment with RNase in vitro 
(Supplementary Fig. 9). When miR-375, conjugated to fluorophore and quencher, was administered orally to 
mice, only a minimal signal was detected in heart and spleen. In contrast, when synthetic 5ATTO633N-labeled 
Figure 3. Bioavailability and distribution of fluorophore-labeled RNAs transfected into bovine milk exosomes 
and administered to mice. (a) Fluorescence signal from Exo-Glow-labeled RNA, delivered through oral gavage 
of bovine milk exosomes (1 × 1012/g body weight) in Balb/c mice 12 hours after administration. (b) Distribution 
of synthetic IRDye-labeled miR-320a, transfected into milk exosomes (1 × 1012/g body weight) 6 hours after 
delivery of exosomes by oral gavage in Balb/c mice. (c) Densitometry analysis of miR-320a distribution shown 
in panel b. (d) Distribution of synthetic IRDye-labeled miR-34a, transfected into milk exosomes (1 × 1012/g 
body weight) 6 hours after delivery of exosomes by oral gavage in Balb/c mice. Data from two experiments are 
shown. (e) Densitometry analysis of miR-34a distribution shown in panel d. (f) Distribution of synthetic IRDye-
labeled miR-155-5p, transfected into milk exosomes (1 × 1012/g body weight) 6 hours after delivery of exosomes 
by oral gavage in Balb/c mice (n = 3). (g) Densitometry analysis of miR-155-5p distribution shown in panel f. 
Panels in this figure were assembled from multiple independent images; individual images in the grouped figure 
are separated by white space.
www.nature.com/scientificreports/
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miR-375 (no quencher) was administered orally to mice, the signal localized primarily to the intestines, with 
minor signal being detectable in kidneys, brain and liver (Fig. 4).
We determined whether bovine milk exosomes deliver bioactive microRNAs in quantities sufficient to res-
cue Drosha knockout mice, which cannot synthesize mature microRNAs except for a few Drosha-independent 
microRNAs36. Mice were fed a bovine milk exosome and RNA-sufficient (ERS) diet or an exosome and 
RNA-depleted (ERD) diet and Drosha was knocked out ubiquitously by tamoxifen administration at age 21 days; 
both diets were based on the AIN-93G formula and were identical for all compounds other than exosomes and 
RNAs. Note that the ERD diet was prepared by using ultrasonicated milk as a supplement and ultrasonicated 
exosomes are not bioavailable (see above). The lifespan of mice fed the ERS diet (8.3 ± 0.5 d) was not significantly 
different from that of mice fed the ERD diet (7.2 ± 0.4 d; p > 0.05; n = 10 per group).
Discussion
This report represents a major advance in our understanding of the bioavailability and distribution of dietary 
(milk) exosomes and their cargos within and beyond species boundaries. Key advances include the following 
discoveries. First, our findings suggest that bovine milk exosomes are bioavailable and accumulate primarily 
in the liver and, to a lesser extent, in the spleen of mice. This paper and a previous report suggest that resident 
macrophages in liver and spleen are responsible for clearing foreign exosomes administered to mice31. Our find-
ings are only partially consistent with another previous report suggesting that bovine milk exosomes distribute 
widely among murine tissues19. The different findings in that previous report and our paper could be attributed 
to the fact that the previous report did not use controls (e.g., free fluorophore or unlabeled exosomes) and used 
oral doses 4-fold higher than those used in our paper19. The accurate identification of exosome target tissues is 
an important topic, because of efforts to use milk exosomes as vehicles for drug delivery19,20. Based on this paper, 
we propose that bovine exosomes might represent an excellent vehicle for delivering drugs to macrophages and 
that homing signals within milk exosomes need to be identified that allow targeting drug-loaded milk exosomes 
to cell lineages other than macrophages. In this context, possible effects of sex on the metabolism of bovine milk 
exosomes need to be explored since florescent signal was reduced in organs of male mice. The choice of controls is 
an important consideration in exosome labeling studies. We propose that the administration of free DiR produces 
an artificially high background signal, based upon the following rationale. The dose of free DiR administered 
to mice is the same as the amount of DiR used for exosome labeling. However, not all the DiR used in labeling 
studies binds to exosomes and the unbound fraction was removed prior to the administration of DiR-labeled 
exosomes to mice. This being said, we erred on the side of caution and used the signal produced by free DiR in 
statistical comparisons with the signal produced by DiR-labeled exosomes. All tracers used in this study, except 
for DiR, consistently suggest that milk exosomes and their cargos accumulate in brain, which is consistent with 
Figure 4. Assessment of microRNA degradation using a dual-label protocol in mice. Distribution of synthetic 
5ATTO633N-miR-375 and the corresponding quencher (3IAbRQSp) transfected into milk exosomes 
(1 × 1012/g of body weight) 6 hours after delivery of exosomes by oral gavage in Balb/c mice. The transfection 
with 5ATTO633N only was used as a control of transfection efficiency and labeling stability. Panels in this figure 
were assembled from multiple independent images; individual images in the grouped figure are separated by 
white space.
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the delivery of Cre recombinase to the brain by exosomes in a previous report32. We propose that the bioavail-
ability and distribution patterns observed for Exo-Glow, fusion proteins and fluorophore-labeled microRNAs 
represent a more accurate picture of exosome bioavailability and distribution than the pattern observed for the 
less stable DiR-label34.
Second, this is the first report to use exosomes endogenously labeled with fluorescent proteins in milk from 
transgenic pigs and mice. Our studies in these animals suggest that milk exosomes, delivered within species 
boundaries through the natural route of suckling, distributes differently than foreign milk exosomes. Autologous 
milk exosomes can be detected in most tissues studied, including the brain. The delivery of exosomes and their 
protein cargos (ZsGreen1 and CD63/eGFP) is consistent with a previous study suggesting that exosomes endog-
enously loaded with Cre recombinase deliver the cargo to various brain regions in Cre reporter mice32. The accu-
mulation of exosomes and their cargos in the brain is of particular interest in the context of ongoing studies in our 
laboratory, suggesting that dietary depletion of milk exosomes and their cargos causes a loss of spatial learning 
and memory in mice27. The loss in spatial learning and memory might be due to the aberrant metabolism of 
purines that has been observed in humans and infants as well as mice fed exosome and RNA cargo-depleted 
diets26; spatial learning and memory depends on purinergic receptor signaling26,37. These studies in transgenic 
pigs and mice also added a new dimension to previous work by suggesting that the consumption of physiological 
amounts of exosomes through the natural route of suckling causes a detectable accumulation of exosomes in the 
tissues of piglets and mouse pups. We anticipate that these observations will be an incentive for conducting stud-
ies of exosomes and their cargos in human milk and their roles in infant nutrition.
Third, this report provides strong evidence that the milk exosome signal in tissues is not an artifact caused by 
tracking fluorophores detached from exosomes. While the transfer of lipophilic labels such as DiR from exosomes 
to proteins and lipoproteins is possible34, our green fluorescent proteins in porcine milk and presumably murine 
milk were stable. Label stability was further confirmed using synthetic miR-375 covalently modified with fluoro-
phore and quencher and administered to mice by using bovine milk exosomes as vehicle. These are significant 
observations in the context of dietary exosomes and cargos, which has been a contested field of study17,38–42.
Fourth, this is the first report that analyzes the biodistribution of different microRNA cargos in bovine milk 
exosomes. The bulk of endogenous RNAs from exosomes accumulates in the spleen and brain, which is distinct 
from the distribution of the exosomes themselves. We speculate that microRNA cargos may be transferred from 
foreign milk exosomes to endogenous exosomes for delivery to the brain, but this theory remains to be tested. 
When we increased the resolution of the distribution studies by using synthetic fluorophore-labeled microRNAs, 
as opposed to using the universal Exo-Glow label, a unique pattern of RNA distribution became apparent. Two 
examples are worth highlighting. MiR-34a has been implicated in spatial cognitive function, hippocampal neuro-
genesis and brain aging43,44. Synthetic miR-34a, transfected into bovine milk exosomes, accumulated primarily in 
the brain. We speculate that the distribution of microRNAs depends not only on the abundance of complemen-
tary mRNAs in tissues, analogous to the principle used in microRNA sponges45, but also on the sequence motif 
of miRNAs that can bind to ribonucleoproteins and facilitate miRNA sorting and packaging into exosomes46.
Fifth, the apparent bioavailability of DiR-labeled exosomes, but not RNA cargos is low. That said, the methods 
used to assess the bioavailability of DiR-labeled exosomes depended on the use of single time points in single 
tissues and therefore may not represent the true bioavailability. The pharmacokinetics of compounds may greatly 
depend on the route of administration47. Loss of label in the intestine might be another explanation, particu-
larly when considering that the apparent bioavailability of synthetic miR-320a approached 25%. In addition, 
it is plausible to propose that the bioavailability of milk exosomes within species boundaries is higher than the 
bioavailability of exosomes beyond species boundaries. Along the lines of bioavailability, feeding the ERS diet 
did not significantly extend the lifespan of Drosha knockout mice compared to mice fed the ERD diet. Failure to 
rescue the mice is probably due to inadequate quality and relatively low bioavailability of milk microRNAs. For 
example, about 400 microRNAs have been identified in bovine milk, whereas about 2000 mature murine microR-
NAs have been identified. Thus, the microRNAs delivered by bovine milk likely lack some microRNAs essential 
for mice48,49.
The findings reported here are guiding ongoing studies in our laboratory. We are in the process of examining 
the phenotypes of dietary depletion of exosomes and their cargos. As described above, some phenotypes have 
already emerged and include aberrant metabolism of purines, impaired spatial learning and memory, regulation 
of DNA methyltransferase 1, as well as impaired resistance to seizures caused by kainic acid21,26,27. Based on the 
observation that a fraction of dietary exosomes and RNAs are not absorbed and enter the large intestine, it will 
be important to understand the biological effects of milk exosomes and cargos on microbial communities in 
the gut. Finally, microRNAs are not the only species of RNA in milk exosomes. It will be worthwhile to explore 
the biological effects of exosome-dependent delivery of RNAs other than microRNAs beyond and within spe-
cies boundaries. For example, single-stranded RNAs are ligands for Toll-like receptors, which is consistent with 
immunomodulatory effects of milk in infants50,51.
Methods
Animals. All animal procedures (animal handling, experimental procedure, anesthesia and euthanasia) were 
conducted in accordance with the University of Nebraska-Lincoln’s Institutional Animal Care and Use Committee 
and approved by the Institutional Animal Care Program (protocol 1229). Studies were conducted in female Balb/c 
mice (Jackson Laboratory, stock number 000651), ages 8 to 20 weeks, unless noted otherwise. Exosome and 
Cargo Tracking (ECT) mice were developed in our laboratory and express an exosome marker protein (CD63) 
fused to eGFP. The presence of the CD63/eGFP gene was confirmed by PCR (Table 1); expression of the trans-
gene was confirmed by imaging green fluorescence (excitation 455–495 nm, emission 503–523 nm). Homozygous 
Drosha knockout mice52, a gift by Dr. Tatsuya Kobayashi (Massachusetts General Hospital), were mated to tamox-
ifen-inducible R26CreER mice (Jackson Labs, stock number: 004847). Homozygous tamoxifen-inducible Drosha 
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knockout mice were identified by PCR (Table 1). Transgenic pigs with ubiquitous ZsGreen1 expression were 
developed as described previously53.
Exosome isolation and authentication. Fat-free pasteurized (skim) bovine milk was obtained from a 
local grocery store; for pasteurization the milk was heated at 71.6 °C for 15 seconds. We chose fat-free pasteur-
ized milk rather than ultra-heat treated milk, because ultra-heat treatment causes a loss of milk microRNAs 
and presumably exosomes54. Exosomes were isolated by ultracentrifugation as described previously, with minor 
modifications15,18. The combined use of fat-free milk and exosome purification by ultracentrifugation minimized 
sample contamination with fat globules, which may also contain microRNAs55. Exosomes were authenticated by 
transmission electron microscopy, nanoparticle tracking analysis (NanoSight NS300, Malvern, Inc.), and west-
ern blot analysis following the guidelines by the International Society for Extracellular Vesicles (Supplementary 
Fig. 10)16,56. Exosomes were suspended in sterile phosphate-buffered saline (PBS) and stored at −80 °C for up to 
120 days57. Porcine milk exosomes were isolated as described above; the presence of ZsGreen1 was confirmed by 
western blot analysis using anti-ZsGreen1 (cat #: 632598; Clontech) and by assessing ZsGreen1 fluorescence in an 
iBox small animal imaging system (UVP LLC).
Some experiments were conducted in mice depleted of macrophages by treatment with 150 μl clodronate 
liposomes (clophosome-ATM, FormuMax, Inc.) administered intraperitoneally 24 hours before exosome admin-
istration31; controls were treated with PBS (Supplementary Fig. 5). Selected experiments were conducted using 
exosomes depleted of surface proteins by treatment with 50 µg/ml trypsin at 37 °C for 30 min, followed by a wash 
with sterile PBS (120,000 × g for 1.5 h) and resuspension in sterile PBS. Experiments of depletion of exosomes 
from milk were performed ultrasonicating milk for 1 hour and followed by incubation at 37 °C for 1 hour before 
exosome isolation (Branson 5800; 47 kHz frequency and 185 Watt peak power).
Labeling of exosomes and RNAs with synthetic fluorophores. Exosomes were labeled with the 
lipophilic fluorophore 1,1-dioctadecyl-3,3,3,3-tetrametylindotricarbocyanine iodide (DiR) as described previ-
ously58. The signal of DiR-labeled exosomes in murine tissues was compared to those produced by an equal 
number of exosomes and free DiR. Only when the signal of DiR-labeled exosomes was significantly greater than 
signals produced by free DiR, tissues were considered potential sites of exosome accumulation. This approach 
represents a conservative method to identifying exosome accumulation sites (see Discussion). If images were 
collected in independent sessions, the signal intensity was normalized across plates by using the signal inten-
sities in tissue-free sections of the plates as reference. RNAs endogenous to bovine milk exosomes were labeled 
using Acridine Orange chemistry (Exo-Glow Red kit, System Biosciences, Inc.) according to the manufacturer’s 
instructions; the stain allows for tracking of the entire pool of single-stranded RNAs. Some exosomes were trans-
fected with synthetic miR-375, labeled with a fluorophore (5ATTO633N,excitation 635, emission 653 nm) and the 
corresponding quencher 3IAbRQSp (ITDNA, Inc), or IRDye-labeled miR-320a, miR-155 or miR-34a (IDTDNA, 
Inc). For transfection, 1 × 1012 exosomes were incubated with 120 pmoles microRNA), 0.5 mM calcium chloride 
and 40% ethanol in a volume of 1 ml for 15 minutes (personal communication by Drs T. Ochiya and K. Othsuka 
K. and Ochiya T., Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, 5-1-1, 
Tsukiji, Chuo-ku, Tokyo, Japan). Free dyes and extra-exosomal synthetic microRNAs were removed by two PBS 
washes (120,000 × g for 60 min), and 1 × 1012 exosomes were administered per g body weight in a volume of less 
than 150 μl. Untransfected controls were prepared by omitting calcium chloride and ethanol. All exosome prepa-
rations were utilized within 2 hours.
Rescue experiments. Tamoxifen-inducible Drosha knockout mice were fed exosome and RNA-depleted 
(ERD) diets or exosome and RNA-sufficient (ERS) diets starting at 3 weeks of age13. Unbiased randomization was 
achieved by numbering the mice and assigning numbers to treatment groups using a blinded design59. At 3 weeks 
of age, tamoxifen was administered intraperitoneally (~80 mg/kg body weight), followed by a second injection 
48 hours later60. Mice were monitored for survival at 12-hour intervals.
Imaging experiments. Fluorescence intensities were assessed at timed intervals for up to 48 hours after 
exosome administration using an iBox small animal imaging system and customized wavelength filters (UVP, 
LLC) for live animals or a LI-COR Odyssey® imaging system (LI-COR Biosciences) for excised organs. Imaging 
experiments were conducted primarily in dissected tissues that were rinsed with cold PBS to remove blood; some 
experiments were conducted in live mice anesthetized with isoflurane. DiR-labeled exosomes and IRDye-labeled 
microRNAs were assessed using 748 nm for excitation and 780 nm for emission. Dissected tissues were rinsed in 
cold PBS and fluorescence was detected by using LI-COR Odyssey® imaging system within 1 hour post-mortem; 
Primers Gene
5′-GCAGAAAGTCTCCCACTCCTAACCTTC-3′ (F) Drosha
5′-CCAGGGGAAATTAAACGAGACTCC-3′ (R)
5′-AAGGGAGCTGCAGTGGAGTA-3′ (F) Cre
5′-CCGAAAATCTGTGGGAAGTC-3′ (R)
5′-TCTTGCGAACCTCATCACTC-3′ (R)
5′-GCAAGAGGTGCGGAAGATTA-3′ (F) CD63/eGFP
5′-GGATGGCGAAGCTAAGATCAA-3′ (R)
Table 1. PCR primers.
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densitometry analysis was performed with LI-COR Image Studio Lite software. Acridine Orange Exo-Glow 
Red-labeled RNA was detected in dissected tissues by using iBox small animal imaging system with custom-
ized wavelength filters (460 nm excitation, 650 nm emission) and densitometry analysis was performed with 
VisionWorks® LS software (UVP, LLC.). The distribution of endogenously labeled ECT exosomes in murine 
tissues was analyzed by using an iBox small animal imaging system and VisionWorks® LS software.
Since ECT dams are hemizygous, matings with WT male mice result in litters that are 50% WT and 50% hem-
izygous for the CD63/eGFP transgene. Litters born to ECT dams were nursed for 17 days; pups were euthanized 
and WT pups were identified by genotyping. The accumulation of CD63/eGFP-labeled exosomes was analyzed in 
excised tissues, such as liver, lungs, brain, kidneys, spleen, heart and the intestine by using an iBox small animal 
imaging system (UVP LLC.). WT pups nursed by WT dams were used as negative controls. The experimental 
design was the same in ZsGreen1 pigs. WT piglets were nursed by transgenic ZsGreen1 sows for 17 days and 
tissues were collected and analyzed by western blot analysis using anti-ZsGreen1. WT piglets nursed by WT 
sows and stillborn WT piglets were used as negative controls. For studies of ZsGreen1-labeled exosomes in mice, 
porcine milk was manually collected and frozen at −20 °C until use.
Statistics. Statistical analysis was performed using Prism 7.0 (GraphPad Software Inc.) by using the t-test for 
p-values. All results are expressed as the mean ± standard deviation (SD).
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